A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION

Name: A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION
License: Public Domain

University Health Network, Toronto

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non small cell lung cancer, renal cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 471463
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.